Drug intelligence / Profile preview

Nanocyn

Development stage
Unknown
Lead developer
Sonoma Pharmaceuticals
Modality
Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Device-based Delivery → Drug Delivery Systems
Administration
Topical/surface Application (hard Nonporous Surfaces), Misting/fumigation/electrostatic Spray Device-assisted Application[3][7]
01

Overview

Nanocyn is a hospital-grade, super-oxidized, pH-neutral, water-based disinfectant and sanitizer designed for use on hard, non-porous surfaces. It utilizes patented Microcyn technology based on stabilized hypochlorous acid (HOCl) to rapidly kill a broad spectrum of bacteria (including MRSA and E. coli), viruses (including SARS-CoV-2/COVID-19, Norovirus), fungi (such as Candida auris), and spores (such as Clostridium difficile). The mechanism involves oxidation of microbial membranes leading to cell death and inhibition of DNA replication. It is non-toxic, hypoallergenic, 100% biodegradable, non-corrosive to materials or equipment, requires no safety equipment for use, leaves no hazardous residues or odors behind after application, and is safe for humans and the environment. Approved by regulatory agencies such as the Australian TGA and US EPA for rapid disinfection in healthcare settings including hospitals and public transport environments[2][3][4][5][6][7][8].

Brand names
Nanocyn
Other names
Nanocyn Disinfectant & SanitiserNanocyn Disinfectant and Sanitizer

Beyond the preview

Go deeper on Nanocyn.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nanocyn.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call